The University of Chicago Header Logo

Connection

J. Thistlethwaite to Female

This is a "connection" page, showing publications J. Thistlethwaite has written about Female.
Connection Strength

0.344
  1. Gender and race/ethnicity differences in living kidney donor demographics: Preference or disparity? Transplant Rev (Orlando). 2021 07; 35(3):100614.
    View in: PubMed
    Score: 0.039
  2. Racial disparities in reaching the renal transplant waitlist: is geography as important as race? Clin Transplant. 2015 Jun; 29(6):531-8.
    View in: PubMed
    Score: 0.026
  3. Outcomes after kidney donation. JAMA. 2014 Jul 02; 312(1):94.
    View in: PubMed
    Score: 0.024
  4. Shared decision making in deceased-donor transplantation. Lancet. 2006 Jul 22; 368(9532):333-7.
    View in: PubMed
    Score: 0.014
  5. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation. 1999 Sep 15; 68(5):608-16.
    View in: PubMed
    Score: 0.009
  6. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. Am J Kidney Dis. 1999 Jul; 34(1):69-84.
    View in: PubMed
    Score: 0.009
  7. Liver transplantation in the first three months of life. Transplantation. 1998 Sep 15; 66(5):606-9.
    View in: PubMed
    Score: 0.008
  8. Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience. Transplant Proc. 1998 Jun; 30(4):1369-70.
    View in: PubMed
    Score: 0.008
  9. Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases. Transplant Proc. 1998 Mar; 30(2):270-1.
    View in: PubMed
    Score: 0.008
  10. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Mar; 30(2):507-8.
    View in: PubMed
    Score: 0.008
  11. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor. Transplantation. 1996 Nov 27; 62(10):1516-9.
    View in: PubMed
    Score: 0.007
  12. Kidney Donor Profile Index Does Not Accurately Predict the Graft Survival of Pediatric Deceased Donor Kidneys. Transplantation. 2016 Nov; 100(11):2471-2478.
    View in: PubMed
    Score: 0.007
  13. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Transplantation. 1996 Oct 15; 62(7):906-10.
    View in: PubMed
    Score: 0.007
  14. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6.
    View in: PubMed
    Score: 0.007
  15. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
    View in: PubMed
    Score: 0.007
  16. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Clin Transplant. 1996 Aug; 10(4):389-95.
    View in: PubMed
    Score: 0.007
  17. To tell or not to tell: attitudes of transplant surgeons and transplant nephrologists regarding the disclosure of recipient information to living kidney donors. Clin Transplant. 2015 Dec; 29(12):1203-12.
    View in: PubMed
    Score: 0.007
  18. Age and equity in liver transplantation: An organ allocation model. Liver Transpl. 2015 Oct; 21(10):1241-9.
    View in: PubMed
    Score: 0.007
  19. Disclosing Health and Health Behavior Information between Living Donors and Their Recipients. Clin J Am Soc Nephrol. 2015 Sep 04; 10(9):1609-16.
    View in: PubMed
    Score: 0.007
  20. Primum non nocere: shared informed decision making in low back pain--a pilot cluster randomised trial. BMC Musculoskelet Disord. 2014 Aug 21; 15:282.
    View in: PubMed
    Score: 0.006
  21. Decision making in liver transplantation--limited application of the liver donor risk index. Liver Transpl. 2014 Jul; 20(7):831-7.
    View in: PubMed
    Score: 0.006
  22. The correlation between donor characteristics and the success of human islet isolation. Transplantation. 1994 Mar 27; 57(6):954-8.
    View in: PubMed
    Score: 0.006
  23. Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1. Lancet. 1993 Sep 25; 342(8874):779-80.
    View in: PubMed
    Score: 0.006
  24. A K-nearest neighbors survival probability prediction method. Stat Med. 2013 May 30; 32(12):2062-9.
    View in: PubMed
    Score: 0.006
  25. OKT3 induction in pediatric renal transplantation. Pediatr Nephrol. 1993 Feb; 7(1):45-9.
    View in: PubMed
    Score: 0.005
  26. Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation. Diabetes. 1992 Oct; 41(10):1346-54.
    View in: PubMed
    Score: 0.005
  27. Innovative use of organs for liver transplantation. Transplant Proc. 1991 Aug; 23(4):2147-51.
    View in: PubMed
    Score: 0.005
  28. What are the perceived learning needs of Australian general practice registrars for quality prescribing? BMC Med Educ. 2010 Dec 09; 10:92.
    View in: PubMed
    Score: 0.005
  29. Selective OKT3 induction therapy in adult cadaveric-donor renal transplant recipients. Am J Kidney Dis. 1989 Nov; 14(5 Suppl 2):28-34.
    View in: PubMed
    Score: 0.004
  30. Minors as living solid-organ donors. Pediatrics. 2008 Aug; 122(2):454-61.
    View in: PubMed
    Score: 0.004
  31. Pelvic examination of asymptomatic women - attitudes and clinical practice. Aust Fam Physician. 2008 Jun; 37(6):493-6.
    View in: PubMed
    Score: 0.004
  32. An empirical investigation of physicians' attitudes toward intrasibling kidney donation by minor twins. Transplantation. 2008 May 15; 85(9):1235-9.
    View in: PubMed
    Score: 0.004
  33. Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection. Am J Kidney Dis. 1988 Feb; 11(2):94-8.
    View in: PubMed
    Score: 0.004
  34. OKT3 treatment of steroid-resistant renal allograft rejection. Transplantation. 1987 Feb; 43(2):176-84.
    View in: PubMed
    Score: 0.004
  35. Omega jejunoduodenal anastomosis for pancreas transplant. J Am Coll Surg. 2006 Jun; 202(6):1021-4.
    View in: PubMed
    Score: 0.003
  36. Attitudes of minority patients with end-stage renal disease regarding ABO-incompatible list-paired exchanges. Am J Transplant. 2006 Jan; 6(1):83-8.
    View in: PubMed
    Score: 0.003
  37. Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation. Hum Immunol. 1985 Nov; 14(3):314-23.
    View in: PubMed
    Score: 0.003
  38. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation. 2005 Jan 27; 79(2):228-35.
    View in: PubMed
    Score: 0.003
  39. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation. 2002 Apr 15; 73(7):1166-9.
    View in: PubMed
    Score: 0.003
  40. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol. 2001 Feb; 32(2):205-15.
    View in: PubMed
    Score: 0.002
  41. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. Transplantation. 1999 Oct 27; 68(8):1117-24.
    View in: PubMed
    Score: 0.002
  42. Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients. Am J Kidney Dis. 1999 Sep; 34(3):540-8.
    View in: PubMed
    Score: 0.002
  43. The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol. 1999 Aug; 10(8):1806-14.
    View in: PubMed
    Score: 0.002
  44. Imaging of pancreatic transplantation using portal venous and enteric exocrine drainage. AJR Am J Roentgenol. 1998 Jul; 171(1):157-63.
    View in: PubMed
    Score: 0.002
  45. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Transplant Proc. 1998 Jun; 30(4):1234-5.
    View in: PubMed
    Score: 0.002
  46. Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1378-9.
    View in: PubMed
    Score: 0.002
  47. Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol. 1998 Apr; 9(4):677-83.
    View in: PubMed
    Score: 0.002
  48. Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Transplantation. 1997 Jul 27; 64(2):258-63.
    View in: PubMed
    Score: 0.002
  49. Bone allografts are immunogenic and may preclude subsequent organ transplants. Clin Orthop Relat Res. 1997 Jul; (340):215-9.
    View in: PubMed
    Score: 0.002
  50. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group. Transplant Proc. 1996 Dec; 28(6):3163-4.
    View in: PubMed
    Score: 0.002
  51. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation. 1996 Sep 15; 62(5):594-9.
    View in: PubMed
    Score: 0.002
  52. Angiographic selection criteria for living related liver transplant donors. AJR Am J Roentgenol. 1996 May; 166(5):1103-8.
    View in: PubMed
    Score: 0.002
  53. OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival. Kidney Int. 1996 Mar; 49(3):768-72.
    View in: PubMed
    Score: 0.002
  54. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995 Jul 01; 123(1):18-26.
    View in: PubMed
    Score: 0.002
  55. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation. Transplantation. 1993 Jan; 55(1):44-50.
    View in: PubMed
    Score: 0.001
  56. Abdominal pain in a young girl due to congenital stenosis of the common bile duct with mucus plug formation. J Pediatr Gastroenterol Nutr. 1992 Nov; 15(4):440-3.
    View in: PubMed
    Score: 0.001
  57. Hepatic artery thrombosis in infants. A comparison of whole livers, reduced-size grafts, and grafts from living-related donors. Transplantation. 1992 Feb; 53(2):396-9.
    View in: PubMed
    Score: 0.001
  58. Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg. 1991 Oct; 214(4):428-37; discussion 437-9.
    View in: PubMed
    Score: 0.001
  59. Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients. Am J Nephrol. 1991; 11(6):470-4.
    View in: PubMed
    Score: 0.001
  60. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg. 1990 Sep; 212(3):368-75; discussion 375-7.
    View in: PubMed
    Score: 0.001
  61. Transplantation of two patients with one liver. Analysis of a preliminary experience with 'split-liver' grafting. Ann Surg. 1990 Jul; 212(1):14-22.
    View in: PubMed
    Score: 0.001
  62. Successful hepatic transplantation in congenital absence of recipient portal vein. Surgery. 1990 Apr; 107(4):475-9.
    View in: PubMed
    Score: 0.001
  63. Experience with radical resection in the management of proximal bile duct cancer. HPB Surg. 1989 Nov; 1(4):297-305; discussion 305-7.
    View in: PubMed
    Score: 0.001
  64. [Heterotopic or orthotopic liver replacement with liver segments?]. Z Gastroenterol Verh. 1987 Apr; 22:66-72.
    View in: PubMed
    Score: 0.001
  65. Cholecystitis and cholelithiasis in young women following pregnancy. Surgery. 1950 Dec; 28(6):983-96.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.